Emergency Management of Accidental Medication Ingestion: A Review of Clinical Risks, Assessment, and Multidisciplinary Interventions
DOI:
https://doi.org/10.22399/ijcesen.4321Keywords:
Accidental medication ingestion, emergency management, assessment, clinical risks, multidisciplinary interventions, toxicologyAbstract
Accidental medication ingestion, particularly among children and vulnerable populations, presents significant clinical risks that necessitate prompt and effective emergency management. The types of medications involved can vary widely from over-the-counter drugs to potent pharmaceuticals, each carrying distinct toxicological profiles. A thorough assessment is crucial in the emergency setting, where healthcare providers must quickly ascertain the type and dosage of the ingested substance, as well as the time elapsed since ingestion. This rapid evaluation informs the decision-making process regarding decontamination procedures, the necessity for activated charcoal administration, and the potential requirement for advanced interventions such as antidote therapy or supportive care measures. The management of accidental medication ingestion requires a multidisciplinary approach, integrating the expertise of emergency physicians, toxicologists, nursing staff, and pharmacists to provide optimal care. Collaboration among these professionals facilitates the development of comprehensive treatment protocols tailored to individual cases, which include ongoing monitoring and re-evaluation of the patient’s clinical status. Educational initiatives aimed at caregivers and the community are also vital to enhance awareness of medication safety and prevention strategies. By improving understanding of risks and proper storage practices, the incidence of accidental ingestions can be reduced, ultimately leading to better health outcomes and reduced strain on emergency resources.
References
1. Mydlik M, Derzsiova K, Smolko P. [Hemoperfusion with Amberlite XAD-4 in acute theophylline poisoning] Cas Lek Cesk. 1995;134(5):145–146.
2. Kvist EE, Al-Shurbaji A, Dahl ML. Quantitative pharmacogenetics of nortriptyline: a novel approach. Clin Pharmacokinet. 2001;40(11):869–877.
3. Chen L-L. Chronic renal disease patients with severe star fruit poisoning: hemoperfusion may be an effective alternative therapy. Clin Toxicol. 2005;43(3):197–199.
4. Borron SW. Fomepizole in treatment of uncomplicated ethylene glycol poisoning. Lancet. 1999;354(9181):831.
5. Koh KH. High-flux haemodialysis treatment as treatment for carbamazepine intoxication. Med J Malaysia. 2006;61(1):109–111.
6. Hovda KE. Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases. Clin Nephrol. 2005;64(3):190–197.
7. Koppel C, Thomsen T, Heinemeyer G, Roots I. Acute poisoning with bromofosmethyl (bromophos) J Toxicol Clin Toxicol. 1991;29(2):203–207.
8. Sen S, Jalan R. The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure. Perfusion. 2004;19(Suppl 1):43–48.
9. Panzer U. Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant. 2004;19(8):2157–2158.
10. Shalkham AS, Barbara MK, Robert SH. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis. 2006;48(2):239–241.
11. Kellersmann R, Gassel HJ, Buhler C. Application of Molecular Adsorbent Recirculating System in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences. Liver. 2002;22(Suppl 2):56–58.
12. Brent J. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001;344(6):424–429.
13. Mydlik M, Derzsiova K, Mizla P, Beno P. [Hemoperfusion in mushroom poisoning. Clinical analysis of 58 patients] Cas Lek Cesk. 1993;132(15):464–467.
14. Winchester JF. Dialysis and hemoperfusion in poisoning. Adv Ren Replace Ther. 2002;9(1):26–30.
15. Durakovic Z, Gasparovic V. [Use of extracorporeal circulation in the treatment of 2,4-dichlorophenoxyacetic acid poisoning] Acta Med Iugosl. 1990;44(1):65–73.
16. Brown MJ. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001;108(4):e77.
17. Guo PYF. Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial. 2006;19(1):80–83.
18. Bismuth C. Biological valuation of extracorporeal techniques in acute poisoning. Acta Clin Belg Suppl. 1990;13:20–28.
19. Spiller HA. Management of carbamazepine overdose. Pediatr Emerg Care. 2001;17(6):452–456.
20. Durakovic Z. Combined hemoperfusion and hemodialysis treatment of poisoning with cholinesterase inhibitors. Korean J Intern Med. 1993;8(2):99–102.
21. Pond SM. Extracorporeal techniques in the treatment of poisoned patients. Med J Aust. 1991;154(9):617–622.
22. Kielstein JT. High-flux hemodialysis—an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication. Clin Nephrol. 2002;57(6):484–486.
23. Himmelfarb J. Hemodialysis complications. Am J Kidney Dis. 2005;45(6):1122–1131.
24. Brent J. Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med. 1999;340(11):832–838.
25. Cameron RJ. Efficacy of charcoal hemoperfusion in massive carbamazepine poisoning. J Toxicol Clin Toxicol. 2002;40(4):507–512.
26. Hommann M, Kasakow LB, Geoghegan J. Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. Pediatr Transplant. 2002;6(4):340–343.
27. Deshpande G. Repeat charcoal hemoperfusion treatments in life threatening carbamazepine overdose. Pediatr Nephrol. 1999;13(9):775–777.
28. Toltec International Inc: How hemodialysis (dialysis) works. December 20, 2006. Available at http://www.toltec.biz/how_hemodialysis_works.htm
29. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver. 2002;22(Suppl 2):20–25.
30. Caravati EM. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255–259.
31. Bismuth C, Scherrmann JM, Garnier R. Elimination of paraquat. Dev Toxicol Environ Sci. 1986;12:347–356.
32. Lai MW, Klein-Schwartz W, Rodgers GC. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila) 2006;44(6–7):803–932.
33. Brown RS., Jr. MARS preconditioning for living donor liver transplantation: panacea or placebo? Liver Int. 2005;25(4):692–695.
34. Mydlik M, Mizla P, Klimcik J. [Use of hemoperfusion and cholinesterase in acute poisoning with organophosphate cholinesterase inhibitors—clinical analysis of 50 patients] Vnitr Lek. 1991;37(7–8):645–651.
35. Schuerer DJE, Brophy PD, Maxvold NJ. High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol. 2000;38(3):321–323.
36. Choi JY, Bae SH, Yoon SK. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation—a pilot study. Liver Int. 2005;25(4):740–745.
37. Williams DM. Acute kidney failure: a pediatric experience over 20 years. Arch Pediatr Adolesc Med. 2002;156(9):893–900.
38. Bradberry SM, Vale JA. Multiple-dose activated charcoal: a review of relevant clinical studies. J Toxicol Clin Toxicol. 1995;33(5):407–416.
39. Borkan SC. Extracorporeal therapies for acute intoxications. Crit Care Clin. 2002;18(2):393–420.
40. Kawasaki CI, Nishi R, Uekihara S. How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases? Clin Toxicol (Phila) 2005;43(2):95–99.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
